Related Experiment Video
Updated: Jan 23, 2026

Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
Biomarkers for PTLD diagnosis and therapies
1Department of Surgery/Division of Abdominal Transplantation, Stanford, CA, USA. omm@stanford.edu.
Insights
Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after pediatric transplantation, often linked to Epstein-Barr virus (EBV). Identifying biomarkers is crucial for personalized diagnosis and treatment of EBV+ PTLD.
Area of Science:
- Pediatric Transplantation
- Immunology
- Oncology
Background:
- Post-transplant lymphoproliferative disorder (PTLD) is a significant complication following pediatric transplantation.
- The majority of PTLD cases are associated with Epstein-Barr virus (EBV), leading to EBV+ B cell lymphomas, the primary post-transplant malignancy in children.
- EBV+ PTLD is attributed to impaired immunity against EBV due to immunosuppression, but the precise viral and immune factors remain unclear.
Purpose of the Study:
- To review current biomarker candidates for EBV+ PTLD.
- To explore immune-, viral-, and B cell lymphoma-derived factors as potential biomarkers.
- To highlight the need for personalized approaches in diagnosing and managing EBV+ PTLD.
Main Methods:
- Literature review of immune-, viral-, and B cell lymphoma-derived biomarkers.
- Analysis of current research on EBV+ PTLD pathogenesis.
- Synthesis of information regarding diagnostic and therapeutic strategies.
Main Results:
- EBV+ PTLD is a major challenge in pediatric transplantation, driven by impaired EBV immunity.
- Several candidate biomarkers from immune, viral, and B cell lymphoma sources are under investigation.
- The development of personalized diagnostic and treatment strategies is a key focus.
Conclusions:
- Biomarkers are essential for improving the clinical diagnosis, management, and treatment of EBV+ PTLD in pediatric transplant recipients.
- Further research into viral, immune, and lymphoma-derived factors is needed to identify reliable biomarkers.
- Personalized medicine approaches hold promise for addressing the complexities of EBV+ PTLD.
Abstract:
Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of lymphoproliferative disorders and is a serious complication of pediatric transplantation. The majority of PTLD are associated with Epstein Barr virus (EBV) and the characteristic EBV+ B cell lymphomas are the leading post-transplant malignancy in children. EBV+ PTLD remains a formidable issue in pediatric transplantation and is thought to result from impaired immunity to EBV as a result of immunosuppression. However, the key viral and immune factors that determine whether EBV+ PTLD develops remain unknown. Recently, there has been much interest in developing biomarkers in order to improve and achieve more personalized approaches, in the clinical diagnosis, management, and treatment of EBV+ PTLD. Here, we review the status of immune-, viral-, and B cell lymphoma-derived candidates for biomarkers of EBV+ PTLD.
Related Concept Videos
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Gene Therapy
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
Formulating and Validating Nursing Diagnosis I
There are thirteen domains...
Group Therapy
Diabetes: Symptoms, Diagnosis, and Complications

